BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21877213)

  • 1. Genes of intestinal Escherichia coli and their relation to the inflammatory activity in patients with ulcerative colitis and Crohn's disease.
    Gombošová L; Lazúrová I; Zakuciová M; Curová K; Kmeťová M; Petrášová D; Siegfried L
    Folia Microbiol (Praha); 2011 Sep; 56(5):367-72. PubMed ID: 21877213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.
    Negroni A; Costanzo M; Vitali R; Superti F; Bertuccini L; Tinari A; Minelli F; Di Nardo G; Nuti F; Pierdomenico M; Cucchiara S; Stronati L
    Inflamm Bowel Dis; 2012 May; 18(5):913-24. PubMed ID: 21994005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection.
    Campos N; Magro F; Castro AR; Cabral J; Rodrigues P; Silva R; Appelberg R; Rodrigues S; Lopes S; Macedo G; Sarmento A
    Immunobiology; 2011 Aug; 216(8):961-70. PubMed ID: 21269730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis.
    Small CL; Reid-Yu SA; McPhee JB; Coombes BK
    Nat Commun; 2013; 4():1957. PubMed ID: 23748852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.
    Vazeille E; Buisson A; Bringer MA; Goutte M; Ouchchane L; Hugot JP; de Vallée A; Barnich N; Bommelaer G; Darfeuille-Michaud A
    J Crohns Colitis; 2015 May; 9(5):410-20. PubMed ID: 25805890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease.
    Iebba V; Conte MP; Lepanto MS; Di Nardo G; Santangelo F; Aloi M; Totino V; Checchi MP; Longhi C; Cucchiara S; Schippa S
    Infect Immun; 2012 Apr; 80(4):1408-17. PubMed ID: 22290143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.
    Walczuk U; Sobieszczańska B; Turniak M; Rzeszutko M; Duda-Madej A; Iwańczak B
    Adv Clin Exp Med; 2019 Jul; 28(7):899-905. PubMed ID: 31066244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis.
    Nadalian B; Yadegar A; Houri H; Olfatifar M; Shahrokh S; Asadzadeh Aghdaei H; Suzuki H; Zali MR
    J Gastroenterol Hepatol; 2021 Apr; 36(4):852-863. PubMed ID: 32929762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.
    Elliott TR; Hudspith BN; Wu G; Cooley M; Parkes G; Quiñones B; Randall L; Mandrell RE; Fagerquist CK; Brostoff J; Rayment NB; Boussioutas A; Petrovska L; Sanderson JD
    Inflamm Bowel Dis; 2013 Oct; 19(11):2326-38. PubMed ID: 23989750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].
    De La Fuente M; Chahuán I; Gutiérrez R; Díaz-Jiménez D; Olivares M; Vidal R; Simian D; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2017 Sep; 145(9):1129-1136. PubMed ID: 29424399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
    Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP
    Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G is expressed in intestinal samples of ulcerative colitis and Crohn's disease patients and HLA-G5 expression is differentially correlated with TNF and IL-10 cytokine expression.
    Gomes RG; Brito CAA; Martinelli VF; Santos RND; Gomes FODS; Peixoto CA; Crispim JO; Diniz GTN; Donadi EA; Lucena-Silva N
    Hum Immunol; 2018 Jun; 79(6):477-484. PubMed ID: 29588183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression.
    Sebastián VP; Salazar GA; Coronado-Arrázola I; Schultz BM; Vallejos OP; Berkowitz L; Álvarez-Lobos MM; Riedel CA; Kalergis AM; Bueno SM
    Front Immunol; 2018; 9():1956. PubMed ID: 30258436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
    Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
    J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation.
    Dogan B; Suzuki H; Herlekar D; Sartor RB; Campbell BJ; Roberts CL; Stewart K; Scherl EJ; Araz Y; Bitar PP; Lefébure T; Chandler B; Schukken YH; Stanhope MJ; Simpson KW
    Inflamm Bowel Dis; 2014 Nov; 20(11):1919-32. PubMed ID: 25230163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy.
    Nguyen HT; Dalmasso G; Müller S; Carrière J; Seibold F; Darfeuille-Michaud A
    Gastroenterology; 2014 Feb; 146(2):508-19. PubMed ID: 24148619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients.
    Olsen I; Tollefsen S; Aagaard C; Reitan LJ; Bannantine JP; Andersen P; Sollid LM; Lundin KE
    PLoS One; 2009 May; 4(5):e5641. PubMed ID: 19479064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls.
    Micenková L; Frankovičová L; Jaborníková I; Bosák J; Dítě P; Šmarda J; Vrba M; Ševčíková A; Kmeťová M; Šmajs D
    Int J Med Microbiol; 2018 Jul; 308(5):498-504. PubMed ID: 29735381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.